Department of Orthopaedic Surgery, Massachusetts General Hospital, Boston, Massachusetts, U.S.A.
Department of Orthopaedics, University of California San Diego, San Diego, California, U.S.A.
Arthroscopy. 2022 Aug;38(8):2511-2524. doi: 10.1016/j.arthro.2022.02.008. Epub 2022 Feb 19.
To construct an algorithm to optimize clinical outcomes in subacromial impingement based on current, high-level evidence.
A systematic review of all clinical trials on subacromial impingement published from 1999 to 2020 was performed. Demographic, clinical, range of motion (ROM), and patient-reported outcome measure (PROM) data were collected. Interventions were compared via arm-based Bayesian network meta-analysis in a random-effects model and treatments ranked via surface under the cumulative ranking curves with respect to 3 domains: pain, PROMs, and ROM.
A total of 35 studies comprising 3,643 shoulders (42% female, age 50 ± 5 years) were included. Arthroscopic decompression with acromioplasty ranked much greater than arthroscopic decompression alone for pain relief and PROM improvement, but the difference in absolute PROMs was not statistically significant. Corticosteroid injection (CSI) alone demonstrated inferior outcomes across all 3 domains (pain, PROMs, and ROM) with low cumulative rankings. Physical therapy (PT) with CSI demonstrated moderate-to-excellent clinical improvement across all 3 domains whereas PT alone demonstrated excellent ROM and low-moderate outcomes in pain and PROM domains. PT with nonsteroidal anti-inflammatory drugs or alternative therapies ranked highly for PROM outcomes and moderate for pain and ROM domains. Finally, platelet-rich plasma injections demonstrated moderate outcomes for pain, forward flexion, and abduction with very low-ranking outcomes for PROMs and external rotation.
Arthroscopic decompression with acromioplasty and PT demonstrated superior outcomes whereas CSI demonstrated poor outcomes in all 3 domains (pain, PROMs, and ROM). For patients with significant symptoms, the authors recommend PT with CSI as a first-line treatment, followed by acromioplasty and PT if conservative treatment fails. For patients with symptoms limited to 1 to 2 domains, the authors recommend a shared decision-making approach focusing on treatment rankings within domains pertinent to individual patient symptomatology.
I, systematic review and network meta-analysis of Level I studies.
基于当前的高级证据,构建一种优化肩峰下撞击症临床结果的算法。
对 1999 年至 2020 年期间发表的所有肩峰下撞击症的临床研究进行系统回顾。收集人口统计学、临床、活动范围(ROM)和患者报告的结果测量(PROM)数据。通过基于臂的贝叶斯网络荟萃分析在随机效应模型中比较干预措施,并通过累积排序曲线下面积(SUCRA)针对 3 个领域(疼痛、PROMs 和 ROM)对治疗方法进行排序。
共纳入 35 项研究,涉及 3643 个肩部(42%为女性,年龄 50±5 岁)。与单独的关节镜下减压术相比,关节镜下减压联合肩峰成形术在缓解疼痛和改善 PROM 方面效果更好,但绝对 PROM 的差异无统计学意义。单独使用皮质类固醇注射(CSI)在所有 3 个领域(疼痛、PROMs 和 ROM)的疗效均较差,累积排序较低。联合 CSI 的物理治疗(PT)在所有 3 个领域均表现出中等到极好的临床改善,而单独 PT 则在疼痛和 PROM 领域表现出极好的 ROM 和低中度疗效。联合非甾体抗炎药或替代疗法的 PT 在 PROM 结果方面排名较高,在疼痛和 ROM 领域排名中等。最后,富血小板血浆注射在疼痛、前屈和外展方面表现出中等疗效,而在 PROM 和外旋方面的疗效则较低。
关节镜下减压联合肩峰成形术和 PT 的疗效优于 CSI,CSI 在所有 3 个领域(疼痛、PROMs 和 ROM)的疗效均较差。对于症状明显的患者,作者建议将 CSI 联合 PT 作为一线治疗,如果保守治疗失败,则进行肩峰成形术和 PT。对于症状仅局限于 1 到 2 个领域的患者,作者建议采用关注与患者特定症状相关的特定领域治疗排序的共同决策方法。
I 级研究的系统回顾和网络荟萃分析。